Cargando…
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk
BACKGROUND: Radiomics based on computed tomography (CT) images is potential in promoting individualized treatment of non-small cell lung cancer (NSCLC), however, its role in immunotherapy needs further exploration. The aim of this study was to develop a CT-based radiomics score to predict the effica...
Autores principales: | He, Bing-Xi, Zhong, Yi-Fan, Zhu, Yong-Bei, Deng, Jia-Jun, Fang, Meng-Jie, She, Yun-Lang, Wang, Ting-Ting, Yang, Yang, Sun, Xi-Wen, Belluomini, Lorenzo, Watanabe, Satoshi, Dong, Di, Tian, Jie, Xie, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073735/ https://www.ncbi.nlm.nih.gov/pubmed/35529789 http://dx.doi.org/10.21037/tlcr-22-244 |
Ejemplares similares
-
Cuproptosis scoring model predicts overall survival and assists in immunotherapeutic decision making in pancreatic carcinoma
por: Liu, Tijun, et al.
Publicado: (2022) -
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma
por: Liu, Xi, et al.
Publicado: (2018) -
Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
por: Du, Zhongxiang, et al.
Publicado: (2023) -
Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
por: Xie, Dong, et al.
Publicado: (2020) -
Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification
por: Xu, Jiaxuan, et al.
Publicado: (2022)